[HTML][HTML] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li, J Wu… - Computational and …, 2022 - Elsevier
Abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …
Therapeutic strategies against COVID-19 and structural characterization of SARS-CoV-2: a review
The novel coronavirus, SARS-CoV-2, or 2019-nCoV, which originated in Wuhan, Hubei
province, China in December 2019, is a grave threat to public health worldwide. A total of …
province, China in December 2019, is a grave threat to public health worldwide. A total of …
Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
The global pandemic of coronavirus disease 2019 (COVID-19), caused by novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 7,273,958 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 7,273,958 …
Emerging strategies on in silico drug development against COVID-19: challenges and opportunities
The importance of coronaviruses as human pathogen has been highlighted by the recent
outbreak of SARS-CoV-2 leading to the search of suitable drugs to overcome respiratory …
outbreak of SARS-CoV-2 leading to the search of suitable drugs to overcome respiratory …
A revisit to the research updates of drugs, vaccines, and bioinformatics approaches in combating COVID-19 pandemic
A new strain of coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
responsible for the coronavirus disease 2019 (COVID-19) pandemic was first detected in the …
responsible for the coronavirus disease 2019 (COVID-19) pandemic was first detected in the …
[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
The prevalence of respiratory illness caused by the novel SARS-CoV-2 virus associated with
multiple organ failures is spreading rapidly because of its contagious human-to-human …
multiple organ failures is spreading rapidly because of its contagious human-to-human …
Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
P Chellapandi, S Saranya - Medicinal Chemistry Research, 2020 - Springer
Abstract Coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a global health emergency and no …
syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a global health emergency and no …
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) recently caused a
pandemic outbreak called coronavirus disease 2019 (COVID-19). This disease has initially …
pandemic outbreak called coronavirus disease 2019 (COVID-19). This disease has initially …
[HTML][HTML] Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity
The SARS-CoV2 is a highly contagious pathogen that causes COVID-19 disease. It has
affected millions of people globally with an average lethality of~ 3%. There is an urgent need …
affected millions of people globally with an average lethality of~ 3%. There is an urgent need …
相关搜索
- sars cov covid 19
- sars cov therapeutic strategies
- therapeutic strategies covid 19
- sars cov drug discovery
- therapeutic strategies drug design
- covid 19 drug design
- advances in the development drug design
- sars cov advances in the development
- therapeutic strategies advances in the development
- covid 19 advances in the development
- multipotent drugs sars cov2
- covid 19 pharmacologic agents
- inhibitory activity sars cov2
- sars cov genomics insights
- sars cov natural compounds
- covid 19 genomics insights